SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Instagram Outage Disrupts Thousands of U.S. Users 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
JACKSONVILLE, Fla., March 01, 2016 -- ParkerVision, Inc. (NASDAQ:PRKR) (the “Company”) announced today that on February 29, 2016, it filed a petition for a Writ of Certiorari with the Supreme Court of the United States (“SCOTUS”) requesting a review of the decision of the United States Court of Appeals for the Federal Circuit in ParkerVision v. Qualcomm. ParkerVision is represented by Thomas C. Goldstein, Goldstein & Russell, P.C.
The question that ParkerVision is requesting the SCOTUS to review is “whether and under what circumstances an inconsistency in expert testimony permits a court to set aside a jury verdict and grant the losing party judgment as a matter of law.” A copy of the full petition can be found on ParkerVision’s website at: http://www.parkervision.com/company/public_relations/PatentCase_PDFs/PV_Q_USSC_05.pdf.
ParkerVision’s Chairman and Chief Executive Officer, Jeffrey Parker, commented, “The question posed in our Supreme Court petition is not only an important one for ParkerVision, but an important one for all plaintiffs, particularly innovators who have made significant investments in patented technologies, who believe their innovations are protected by the US patent system, and who rely on the Seventh Amendment guarantee of the right to trial by civil jury and the sanctity of the jury verdict to resolve patent disputes. The large number of jury verdicts reversed by the Federal Circuit in recent years contributes to an environment of uncertainty which threatens the future of innovation. We believe this is a critical issue in today’s patent environment, and the Supreme Court’s acceptance of our petition will be an indication that the highest court recognizes the importance of providing guidance on the appropriate role of the jury and the judge.”
About ParkerVision
ParkerVision, Inc. designs, develops and markets its proprietary radio-frequency (RF) technologies that enable advanced wireless solutions for current and next generation communications networks. Protected by a highly-regarded, worldwide patent portfolio, the Company’s solutions for wireless transfer of RF waveforms address the needs of a broad range of wirelessly connected devices for high levels of RF performance coupled with best-in-class power consumption. For more information please visit www.parkervision.com. (PRKR-G).
Safe Harbor Statement
This press release contains forward-looking information. Readers are cautioned not to place undue reliance on any such forward-looking statements, each of which speaks only as of the date made. Such statements are subject to certain risks and uncertainties which are disclosed in the Company's SEC reports, including the Form 10K for the year ended December 31, 2014 and Forms 10Q for the quarters ended March 31, June 30, and September 30, 2015. These risks and uncertainties could cause actual results to differ materially from those currently anticipated or projected.
Contact: Cindy Poehlman Chief Financial Officer ParkerVision, Inc. 904-732-6100, [email protected] or Don Markley The Piacente Group 212-481-2050, [email protected]
